CombiMatrix to Present at Upcoming Investor Conferences

IRVINE, Calif., May 22, 2017 -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces that management will present at two upcoming investor conferences:

• B. Riley & Co.’s 18^th Annual Investor Conference on Thursday, May 25, at 11:00 a.m. Pacific time.  The conference is being held at the Loews Santa Monica Beach Hotel. 
   
• 7^th Annual LD Micro Invitational on Tuesday, June 6, at 3:00 p.m. Pacific time.  The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

About CombiMatrix Corporation

CombiMatrix Corporation provides sophisticated molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic diagnostics and screening, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. Our testing focuses on advanced technologies, including single nucleotide polymorphism chromosomal microarray analysis, next generation sequencing, fluorescent in situ hybridization and high resolution karyotyping. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.

Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
(949) 753-0624

Investor Contact:
LHA
Jody Cain
(310) 691-7100
[email protected]